Gastroenterology
Volume 136, Issue 3 , Pages 760-763, March 2009

Nitazoxanide: Beyond Parasites Toward a Novel Agent for Hepatitis C

  • Jama M. Darling

      Affiliations

    • Corresponding Author InformationReprint requests Address requests for reprints to: Jama M. Darling, MD, University of North Carolina, CB# 7584, Room 8015 Burnett-Womack Building, Chapel Hill, NC 27599-7584
    • ,
  • Michael W. Fried

Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

published online 23 January 2009.

No abstract is available. To read the body of this article, please view the Full Text online.

 

 Conflicts of interest Michael W. Fried receives grant support from several companies that make competing products including Roche, Vertex, Human Genome Sciences, Wyeth, and Tibotec. He has no interest in or support from Romark, the sponsor of the study this editorial refers to.

 Dr Darling discloses no conflicts.

PII: S0016-5085(09)00050-X

doi:10.1053/j.gastro.2009.01.020

Refers to article:

  • PodcastLinking Article with CGHEditorial Accompanies Article Improved Virologic Response in Chronic Hepatitis C Genotype 4 Treated With Nitazoxanide, Peginterferon, and Ribavirin , 21 November 2008

    Jean–François Rossignol, Asem Elfert, Yehia El–Gohary, Emmet B. Keeffe
    Gastroenterology March 2009 (Vol. 136, Issue 3, Pages 856-862)

Gastroenterology
Volume 136, Issue 3 , Pages 760-763, March 2009

Article Tools

* Image Usage & Resolution